 Laboratory parameters safety efficacy thrombolytic therapy Thrombolytic therapy frequency myocardial infarction MI pulmonary embolism venous thrombosis DVT peripheral arterial occlusion Use agents concerns safety efficacy Numerous laboratory parameters risk complications levels fibrinogen percentage decrease fibrin/fibrinogen degradation products FDPs variable extent clinical bleeding bleeding time BT test potential predictor thrombolytic therapy respect efficacy D-dimer fragment FDPs soluble fibrin polymers clot lysis venous thromboembolism MI BT marker lysis patients DVT concomitant use antiplatelet agents thrombolytic therapy BT vivo test hemostasis platelet function potential utility noninvasive adjunctive marker thrombolytic efficacy